KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Receivables (2020 - 2025)

Clover Health Investments' Change in Receivables history spans 6 years, with the latest figure at $36.9 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 159.58% year-over-year to $36.9 million; the TTM value through Dec 2025 reached $43.3 million, up 443.18%, while the annual FY2025 figure was $43.3 million, 443.18% up from the prior year.
  • Change in Receivables reached $36.9 million in Q4 2025 per CLOV's latest filing, up from $11.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $36.9 million in Q4 2025 to a low of -$29.4 million in Q3 2024.
  • Average Change in Receivables over 5 years is $2.8 million, with a median of $4.3 million recorded in 2023.
  • Peak YoY movement for Change in Receivables: soared 436.92% in 2021, then crashed 2379.85% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $13.4 million in 2021, then increased by 2.81% to $13.8 million in 2022, then decreased by 12.14% to $12.1 million in 2023, then rose by 17.65% to $14.2 million in 2024, then skyrocketed by 159.58% to $36.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Change in Receivables are $36.9 million (Q4 2025), $11.0 million (Q3 2025), and -$6.6 million (Q2 2025).